News

DGCI approves two new antibiotics developed by Wockhardt

This approval by the Indian drug regulator DCGIis claimed to be the country's first new discovery antibiotics.

Jan 17, 2020

By : Team ABLE

DBT invites comments on Draft document on Genome Edited Organisms: Regulatory Framework and Guidelines for Risk Assessment

In view of the recent developments in the field of Genome Editing Technologies a need was felt to bring out guidelines.

Jan 13, 2020

By : Team ABLE

DBT announces Third Call under ATGC program

DBT would enable academic researchers to take their fundamental research to next phase via translational research opportunities under Accelerated Translational Grant for Commercialization (ATGC).

Jan 13, 2020

By : Team ABLE

FDA, USDA, EPA create a joint platform to streamline agricultural biotechnology products’ information

The Unified Website for Biotechnology Regulation describes the federal review process for certain biotechnology products and allows users to submit questions to the three agencies.

Jan 10, 2020

By : Team ABLE

Bolt Biotherapeutics expands Scientific Advisory Board with appointment of Dr. Priti Hegde

Dr. Hegde completed her post-doctoral fellow at The Institute for Genomic Research, holds a Ph.D. in Biochemical Pharmacology from SUNY Buffalo, and a B. Pharmacy from Mumbai University.

Jan 10, 2020

By : Team ABLE